Castuner
Submit a podcast

NEJM Interviews

NEJM Group

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

Podcast website

Listen in your app

Episodes

960 episodes

  1. NEJM Interview: Anjali Deshmukh on legal challenges to fines issued by federal agencies. 14:29
  2. NEJM Interview: Matthew Vogel on the emergence of clinical trial prediction markets. 7:29
  3. NEJM Interview: Lena Makaroun on opportunities for clinicians to address firearm-related risks with their older patients. 13:49
  4. NEJM Interview: Sarah Schmitz on protections for people enrolled in trials of investigational agents for obesity. 5:35
  5. NEJM Interview: Benjamin Scher on opioid litigation and governance systems for spending related funds. 8:50
  6. NEJM Interview: Christopher Forrest on declines in the health of U.S. children and the role of communities in reversing those trends. 13:16
  7. NEJM Interview: Dhruv Khullar on concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory. 9:23
  8. NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services. 11:35
  9. NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion. 11:53
  10. NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research. 13:08
  11. NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement. 8:55
  12. NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness. 11:14
  13. NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health. 14:12
  14. NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines. 8:40
  15. NEJM Interview: Yaara Zisman-Ilani on navigating the uncertainty surrounding medication management in autism care. 8:05
  16. NEJM Interview: Mark Unruh on projected increases in the need for long-term services and supports in the United States amid declines in nursing-home capacity. 5:40
  17. NEJM Interview: Justin Barr on physician leadership in American society and politics over the past 250 years. 11:08
  18. NEJM Interview: Stacie Dusetzina on a new program that will allow Medicare Part D enrollees to obtain GLP-1 medications for use for weight loss. 13:06
  19. NEJM Interview: Marcus Hughes on inconsistent oversight of psychedelic agents at the state and federal levels in the United States. 9:02
  20. NEJM Interview: Edward Ryan on factors driving continued disease and death from cholera and opportunities for progress. 12:17
  21. NEJM Interview: Loren Adler on regulatory strategies for addressing factors that make consolidation in health care especially profitable. 10:14
  22. NEJM Interview: Deirdre Tobias on the 2025–2030 Dietary Guidelines for Americans, including areas of confusion and contradiction. 14:27
  23. NEJM Outbreaks Updates — Andes Hantavirus 27:53
  24. NEJM Interview: Raja-Elie Abdulnour on the need for clinicians and AI systems to refrain from expressing undue confidence in their knowledge. 12:57
  25. NEJM Interview: Jatin Vyas on the effect of corporatization of academic medical centers on medical education and trainee development. 8:53
  26. NEJM Interview: Amanda Banks on concerns about a potential association between GLP-1 receptor agonists and restrictive eating disorders. 9:30
  27. NEJM Interview: Sara Gerke on a Utah pilot program involving an AI system that autonomously renews certain prescriptions. 9:10
  28. NEJM Interview: Amy Stimpfel on a new policy that would cap loans for graduate nursing and other students. 6:34
  29. NEJM Interview: Danielle Jones on the development of tools to help family physicians address social determinants of health and advance health equity. 6:53
  30. NEJM Interview: Lawrence Casalino on qualities of corporate organizations that could affect physicians’ intrinsic motivation and the quality of the care they provide. 12:30
  31. NEJM Interview: Douglas Opel on the importance of clinician–parent communication amid changes to the childhood vaccine schedule. 9:26
  32. NEJM Interview: Abbas Hassan on the gap between the services that residents and fellows provide and the revenue that hospitals can capture. 8:35
  33. NEJM Interview: Ruqaiijah Yearby on recent trends in health care markets and their implications for health equity. 6:44
  34. NEJM Interview: Bruce Chabner on recent FDA statements regarding potential uses for leucovorin. 6:38
  35. NEJM Interview: Sonja Rasmussen on the 2025–2026 influenza season, including factors contributing to the intensity of influenza activity. 5:48
  36. NEJM Interview: Carmel Shachar on the opportunities and risks presented by the Rural Health Transformation Program. 7:40
  37. NEJM Interview: Leemore Dafny on the implications of corporatization of the U.S. health insurance industry. 11:27
  38. NEJM Interview: Robert Kocher on strategies for improving blood-pressure control in the United States. 6:42
  39. NEJM Interview: Tara Eicher on changes in autism diagnosis in recent years and statements from the federal government regarding autism. 14:20
  40. NEJM Interview: Tara Sklar on U.S. telehealth payment policy and the potential for a revised approach to support competition and efficiency. 12:17
  41. NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States. 10:52
  42. NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services. 9:57
  43. NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend. 7:38
  44. NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. 9:57
  45. NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy. 14:43
  46. NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications. 11:49
  47. NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine. 10:34
  48. NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders. 12:30
  49. NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization. 7:38
  50. NEJM Interview: Eberechi Nwogu-Onyemkpa on integrating palliative care services and resources into the management of sickle cell disease. 9:52